HealthQuill Pharma
Forty-five per cent of 82 urban areas in China, with a total population of about 700 million, are sinking — with 16% falling at 10mm a year or more, a study finds.
Climate Health Pharma

Beijing, Tianjin among sinking cities in China, UEA researchers say

HQ Team April 20, 2024: Forty-five percent of 82 urban areas in China, with a total population of about 700 million, are sinking.

Read More
A bacteria that causes infections, including pneumonia, bloodstream infections, and meningitis are being treated by doctors with less effective old generic antibiotics — even though the US regulator has cleared seven next-generation antibiotics to deal with the germs.
Drugs Health Pharma

US doctors still prescribe old generic antibiotics, cost main factor

HQ Team April 20, 2024: A bacteria that causes infections, including pneumonia, bloodstream infections, and meningitis are being treated by doctors with less.

Read More
The WHO, health experts and agencies have agreed on the terminology used to describe the spread of a disease through the air after “airborne” and “aerosol transmission” contributed to misleading information during the Covid-19 pandemic.
Drugs Health Pharma

‘Through the air’ is the new terminology for pathogen spread: UN agency

HQ Team April 19, 2024: The WHO, health experts and agencies have agreed on the terminology used to describe the spread of a.

Read More
Health Medical Pharma

New insights into neurological basis of autism spectrum disorder

HQ Team April 18, 2024: Autism spectrum disorder (ASD) is a complex condition with an array of symptoms and severity levels making it.

Read More
A blood protein, called fibrin, which supports clotting, is responsible for switching on detrimental genes in Alzheimer’s disease and multiple sclerosis, researchers say.
Health Medical Pharma

FDA clears Abbott’s rapid blood test for concussion assessment

HQ  Team April 18, 2024: The Food and Drug Administration (FDA) has cleared Abbot’s i-STAT TBI cartridge for rapid assessment of mild traumatic.

Read More
The WHO has sounded a global alert on a batch of substandard cough syrup found in Cameroon, which has high levels of a toxic ingredient, diethylene glycol.
Drugs Medical Pharma

Six African nations recall J&J manufactured cough syrup after suspicious toxicity reports

HQ Team April 17, 2024: Drug regulatory authorities in South Africa, Tanzania, Rwanda, Nigeria, Kenya, Eswatini and Zimbabwe have issued a recall for.

Read More
FoMo has been conceptualised as a negative emotion due to unmet relatedness needs. It may be episodic as in a single conversation or a long-term disposition. Too much exposure to others’ activities results in a feeling of self-doubt and inadequacy — a feeling of “whether I am enough.”
Drugs Health Opinion Pharma

Opinion: FoMo’s ‘compulsive connectivity’ may cause anxiety

By Aparna S April 14, 2024: Social media has remodelled communication in good and bad ways. Those who have been increasingly lonely find.

Read More
Global temperatures associated with climate change may result in a stroke leading to death and disability, a study found.
Climate Drugs Pharma

Global stroke deaths may be linked to climate change: Study reports

HQ Team April 12, 2024: Global temperatures associated with climate change may result in strokes leading to death and disability, a study found..

Read More
Anglo-Swedish drugmaker, AstraZeneca will acquire clinical-stage Fusion Pharmaceuticals for $2 billion in cash to get access to the latter’s radioconjugates to treat cancer.
Drugs Medical Pharma

FDA’s accelerated approval of cancer drugs is hasty and doubtful, says new report

HQ Team April 10, 2024:  A new study has found that cancer drugs that got accelerated approval under the US Federal Drug Approval.

Read More
Synchron, a US-based brain implant company, plans to recruit motor-impaired patients for its clinical trial in competition with Elon Musk’s Neurolink.
Drugs Health Pharma

Rivalling Elon Musk’s Neurolink, Synchron plans brain implant trial 

HQ Team April 9, 2024: Synchron, a US-based brain implant company, plans to recruit motor-impaired patients for its clinical trial in competition with.

Read More